Latest Modified vaccinia Ankara Stories
How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response.
Phase I clinical trials reveal MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV).
ATLANTA, June 8, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX) announced today the publication of the results of preclinical testing of a simian prototype of its 2nd generation HIV/AIDS vaccine.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.